- Printed Journal
- Indexed Journal
- Refereed Journal
- Peer Reviewed Journal
P-ISSN: 2664-7591
E-ISSN: 2664-7605
Working hours 10:00 AM-06:00 PM
| S. No. | Title and Authors Name |
|---|---|
| 1 |
A comprehensive study on topiramate transdermal drug delivery systems
Jitendra Annasaheb Kubde and Dr. Suraj M Sarode
Int. J. Pharm. Clin. Res., 2024; 6(1): 01-06
|
| 2 |
Regulatory requirements: The orphan drugs in various countries
Ranjith Kumar Karunanidhi, Dr. N Senthil Kumar, Senthil Kumar Balakrishnan, Kodali Sirisha, Jeganathan B, Tharani S and Ayesha Thasneem VM
Int. J. Pharm. Clin. Res., 2024; 6(1): 07-14
|
| 3 |
Socioepidemiological and clinical profile of pre-exposure prophylaxis (PrEP) users for HIV: an assessment of adverse effects, drug interactions, and sexually transmitted infections (STIs) incidence
Rodrigo Augusto Mastrella Curado Fleury, Helena Diniz Matos, Beatriz Rodrigues Torres, Ana Vitória Resende Brito, Anna Victoria Gonçalves Martins, Marcelo Cecílio Daher, Osmar Nascimento Silva, Edvande Xavier dos Santos Filho and Emerith Mayra Hungria Pinto
Int. J. Pharm. Clin. Res., 2024; 6(1): 15-20
|
| 4 |
Adamantinoma like Ewing sarcoma of pelvis- A rare tumor at an uncommon site
Dr. Priyanka Gupta, Dr Rohan Gupta and Dr. Ritu Asnani
Int. J. Pharm. Clin. Res., 2024; 6(1): 21-24
|
| 5 |
Computer aided drug design for breast cancer
Prangyasini Devi, Suranjana Sarkar, Subhasis Sarkar, Semanti Ghosh and Bidisha Ghosh
Int. J. Pharm. Clin. Res., 2024; 6(1): 25-28
|
| 6 |
Exploring role of Neurocognitive enhancers in dementia: A comprehensive review
Dr. Anil Gorakhanath Korade
Int. J. Pharm. Clin. Res., 2024; 6(1): 29-40
|
| 7 |
Nanovaccine approach to prevent binding of SARS-CoV-2 surface glycoprotein with ACE2 and TMPRSS2 receptor
Ashish Shivram Ramteke
Int. J. Pharm. Clin. Res., 2024; 6(1): 41-52
|
P-ISSN: 2664-7591
E-ISSN: 2664-7605
Working hours 10:00 AM-06:00 PM
International Journal of Pharmaceutical and Clinical Research
